Volume | 14,423 |
|
|||||
News | - | ||||||
Day High | 3.299 | Low High |
|||||
Day Low | 3.07 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Incannex Healthcare Ltd | IXHL | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
3.20 | 3.07 | 3.299 | 3.25 | 3.20 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
296 | 14,423 | $ 3.15 | $ 45,460 | - | 0.80 - 12.68 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:40:53 | 13 | $ 3.25 | USD |
Incannex Healthcare Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
793.66k | 15.87M | - | 1.01M | -19.98M | -1.26 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Incannex Healthcare News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IXHL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.99 | 3.299 | 2.78 | 3.03 | 23,591 | 0.26 | 8.70% |
1 Month | 2.56 | 3.299 | 2.39 | 2.80 | 32,278 | 0.69 | 26.95% |
3 Months | 3.19 | 3.82 | 2.13 | 2.85 | 46,746 | 0.06 | 1.88% |
6 Months | 7.04 | 8.4697 | 2.13 | 5.51 | 175,980 | -3.79 | -53.84% |
1 Year | 1.88 | 12.68 | 0.80 | 4.84 | 132,991 | 1.37 | 72.87% |
3 Years | 11.00 | 90.00 | 0.80 | 7.17 | 87,574 | -7.75 | -70.45% |
5 Years | 11.00 | 90.00 | 0.80 | 7.17 | 87,574 | -7.75 | -70.45% |
Incannex Healthcare Description
Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. |